Antitrust & Trade Reg.
Jun. 16, 2023
FTC accused of delaying cancer breakthrough by blocking merger
The organizations and attorneys general filed briefs this week before the 5th U.S. Circuit Court of Appeals, which is considering Illumina and Grail’s appeal of the FTC’s divestiture order.
A group of Republican attorneys general, Hispanic doctors, law professors and other groups are siding with San Diego-based biotechnology company Illumina Inc. in its battle with the U.S. Federal Trade Commission over whether it can acquire a company that makes blood tests to detect early-stage cancer.
The organizations and attorneys general filed briefs this week before the 5th U.S. Circuit Court of Appeals, which is considering Illumina a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In